Stock Price
2024-10-29
Market Capitalization
2024-08-26
Revenue
FY, 2025




Phase II Trials Products (Oncology)
FY, 2021
Phase III/Filed Trials Products (Oncology)
FY, 2021
Phase I Trials Products (Rare Blood Disorders)
FY, 2020
France
54 Rue la Boétie
United States
55 Corporate Dr
United States
38 Sidney St
United States
50 Binney St
United States
1209 Orange St
United States
3711 Kennett Pike Suite #200